Alzchem Group: Dr. Jürgen Sans Named COO in Succession Success

• Alzchem Group AG has completed its long-term succession planning for the Management Board.
• Dr. Jürgen Sans has been appointed as Chief Operating Officer (COO) effective from January 1, 2026, for a three-year term.
• Dr. Sans has over 27 years of experience with Alzchem and previously led the Innovation and Research & Development division.
• He succeeds Klaus Englmaier, who will retire at the end of 2025 after significantly contributing to the company's development.
• The Management Board will consist of Andreas Niedermaier (CEO), Andreas Lösler (CFO), Martina Spitzer (CSO), and Dr. Jürgen Sans (COO) starting January 1, 2026.
• Alzchem Group AG generated sales of €554.2 million and EBITDA of €105.3 million in 2024, employing around 1,700 people across multiple locations.

The next important date, Publication of the semi-annual financial report, at Alzchem Group is on 30.07.2025.

The price of Alzchem Group at the time of the news was 118,60EUR and was up +0,25 % compared with the previous day.
11 minutes after the article was published, the price was 118,40EUR this corresponds to a minus of -0,17 % since publication.
At this time, the index SDAX was at 16.452,19PKT (+0,18 %).

Alzchem Group

+1,66 %

-3,31 %

+6,27 %

+32,11 %

+177,65 %

+504,82 %

+509,22 %

+326,91 %

ISIN:DE000A2YNT30WKN:A2YNT3

• Intraday
• 5 Tage
• 1 Monat
• 3M
• 1 Jahr
• 3J
• 5J
• Max